The Alcohol Use Disorders Identification Test and the risk of metachronous cancer after endoscopic resection of esophageal cancer
- 11 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 41 (8), 1049-1056
- https://doi.org/10.1093/carcin/bgaa022
Abstract
Follow-up studies of Japanese patients who had undergone endoscopic resection (ER) for early esophageal squamous cell carcinoma (ESCC) have reported a high prevalence of metachronous SCC in the upper aerodigestive tract (UAT). This prospective multicenter cohort study followed up 330 Japanese patients after ER of ESCC for a median of 49.4 months. The Alcohol Use Disorders Identification Test (AUDIT) for the 12-month period prior to study registration revealed high frequencies of high-risk drinking behaviors: 84 (25.4%) subjects had AUDIT scores of ≥15 points (suspected alcohol dependence) and 121 (36.7%) subjects had AUDIT scores of 8–14 points (hazardous drinking). Seventy-four subjects were metachronously diagnosed with ESCC, and 20 subjects with head and neck SCC (HNSCC). AUDIT scores ≥15 were associated with increases in the total number of HNSCCs per 100 person-years (0.4 for 0–7, 1.2 for 8–14 and 7.1 for ≥15; P < 0.0001). AUDIT scores were progressively associated with the grade of esophageal Lugol-voiding lesions (LVLs), a predictor of field cancerization in the UAT. Both an AUDIT score of ≥15 points and the presence of multiple LVLs were independent predictors of metachronous HNSCC [multivariate hazard ratio (95% confidence interval) = 6.98 (1.31–37.09) and 3.19 (1.19–8.54), respectively]. However, a high AUDIT score was not a predictor of metachronous ESCC. In conclusion, high AUDIT scores were markedly frequent in this population and increased the risk of metachronous HNSCC. The assessment of drinking behavior using the AUDIT and the completion of interventions for alcohol problems should be incorporated into the treatment strategy of ESCC. The name of the clinical trial register and the clinical trial registration number: Japan Esophageal Cohort Study, UMIN000001676.Keywords
Funding Information
- National Cancer Center Research and Development Fund (36)
- Ministry of Health, Labor and Welfare of Japan
This publication has 36 references indexed in Scilit:
- Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk allelesGut, 2010
- Polymorphisms of Alcohol Dehydrogenase‐1B and Aldehyde Dehydrogenase‐2 and the Blood and Salivary Ethanol and Acetaldehyde Concentrations of Japanese Alcoholic MenAlcohol: Clinical and Experimental Research, 2010
- Risk of metachronous squamous cell carcinoma in the upper aerodigestive tract of Japanese alcoholic men with esophageal squamous cell carcinoma: a long‐term endoscopic follow‐up studyCancer Science, 2008
- Geographically Separate Increases in the Frequency of the Derived ADH1B*47His Allele in Eastern and Western AsiaAmerican Journal of Human Genetics, 2007
- Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinomaCarcinogenesis: Integrative Cancer Research, 2006
- Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol‐associated cancer in heavy drinkersInternational Journal of Cancer, 2005
- Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck regionCarcinogenesis: Integrative Cancer Research, 2005
- Head and Neck Cancer Arising After Endoscopic Mucosal Resection for Squamous Cell Carcinoma of the EsophagusEndoscopy, 2003
- Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resectionGastrointestinal Endoscopy, 2001
- Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patientsGut, 2000